Re: Levetiracetam Appears Safe, Effective for Treatment of

[Guest guest]

> Now this is bizarre!

>

**** AMEN TO THAT, MICHELLE!

>

> To investigate, Dr. Deutschman and colleagues performed an

> open-label, naturalistic trial in 54 patients,

> 39 men and 15 women, with a median age of 13 years. Patients had

> diagnoses of oppositional defiant

> disorder (ODD, 62%), conduct disorder (CD, 11%), and intermittent

> explosive disorder (IED, 27%)

***** GEE, MY DAUGHTER DIDN'T HAVE ANY OF THESE UNTIL SHE TOOK

KEPPRA...THEN, ALL OF A SUDDEN SHE HAD ALL THREE

>

> The study was funded in part by UCB Pharmaceuticals, the maker of

> Keppra. Dr. Deutschman has been

> a speaker for UCB Pharmaceuticals.

*****HMMMMM.... WONDER IF THIS HAD ANYTHING TO DO WITH THE OUTCOME OF

THE RESULTS???? NOT THAT I'M CYNICAL ABOUT DRUG COMPANIES...

IN ALL FAIRNESS, I HAVE TO SAY THAT I HAVE HEARD AND READ SINCE MARY

WAS ON KEPPRA THAT IT DEFINITELY SHOULD NOT BE USED IN CHILDREN UNDER

12. INTERESTING TO NOTE THAT THE " MEDIAN " AGE IN THIS STUDY WAS 13,

THOUGH.

CAMMIE